Mucosolvan cough syrup

Mucosolvan is a cough syrup containing the active ingredient ambroxol hydrochloride, which acts as a mucolytic agent to thin and loosen mucus in the airways, facilitating expectoration and alleviating coughing. The product is manufactured in various countries, including Germany, France, Greece, and Vietnam, reflecting its widespread production. Sanofi, a global healthcare company headquartered in France, is the ultimate owner of the Mucosolvan brand. The company has a significant presence in the pharmaceutical industry, offering a wide range of products across multiple therapeutic areas. In the United States, Sanofi's subsidiary, Sanofi-Aventis U.S. LLC, manages the distribution and marketing of Mucosolvan, ensuring its availability to American consumers.